SCHEMBL349140

SCHEMBL349140

C1=c2ccccc2=c2ccc3ccc4c5ccccc5c5c(c4c3c21)-c1ccccc1C=5

nearest known ligand 0.30

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 1/20 0.30
▸ CYP1A2 P05177 1/20 0.30
▸ THRB P10828 1/20 0.30
▸ HPGD P15428 1/20 0.30
▸ HSD17B10 Q99714 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29177994 0.67 — —
SCHEMBL4852467 0.67 — —
SCHEMBL31296681 0.66 — —
SCHEMBL17273342 0.66 — —
SCHEMBL30831900 0.66 — —
SCHEMBL28092404 0.65 — —
SCHEMBL4849512 0.64 — —
SCHEMBL16415808 0.61 — —
SCHEMBL4853869 0.60 CDC25A (0.32) —
SCHEMBL1307789 0.59 TNF (0.31) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2419391-B1 NOVEL FUSED POLYCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE CANON KK (JP) 2014-04-30 — — EP disclosed
EP-2419391-A1 NOVEL FUSED POLYCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE Canon Kabushiki Kaisha (JP) 2012-02-22 — — EP disclosed
EP-2417085-A1 NOVEL FUSED POLYCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME Canon Kabushiki Kaisha (JP) 2012-02-15 — — EP disclosed
US-20120013700-A1 NOVEL FUSED POLYCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CANON KABUSHIKI KAISHA (JP) 2012-01-19 — — US disclosed
US-20110315973-A1 NOVEL FUSED POLYCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE CANON KABUSHIKI KAISHA (JP) 2011-12-29 — — US disclosed
WO-2010119914-A1 NOVEL FUSED POLYCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE CANON KABUSHIKI KAISHA (JP) 2010-10-21 — — WO disclosed
WO-2010116661-A1 NOVEL FUSED POLYCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CANON KABUSHIKI KAISHA (JP) 2010-10-14 — — WO disclosed
WO-2004076503-A1 OLEFIN POLYMERIZATION CATALYSTS BASED ON CONVEX, POLYCYCLIC LIGANDS EQUISTAR CHEMICALS LP (US) 2004-09-10 — — WO disclosed
US-6713576-B1 FUSED RING CYCLOPENTADIENE CENTERED METAL COORDINATION CATALYSTS; STABILIZED ACTIVE SITE; MINIMIZING STERIC INTERFERENCE EQUISTAR CHEMICALS, LP 2004-03-30 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110315973-A1 NOVEL FUSED POLYCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE NR2E3, PYM1, TYR ALDH1A1 1824/4885CYP1A2 151/4885THRB 4223/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback